Postdoctoral Fellow - Diabetes and Cancer Metabolism Research jobs in United States
cer-icon
Apply on Employer Site
company-logo

City of Hope · 1 month ago

Postdoctoral Fellow - Diabetes and Cancer Metabolism Research

City of Hope is at the forefront of groundbreaking research, making a real difference in the fight against cancer and diabetes. The postdoctoral position in the Department of Diabetes and Cancer Metabolism focuses on studying the molecular, cellular, and metabolic mechanisms leading to obesity, diabetes, and cancer.

AssociationEducationHealth Care
check
Comp. & Benefits

Responsibilities

Work in the lab utilizes both genetically engineered mouse models and in vitro systems
A combination of state-of-the-art surgical, genetic, cellular, biochemical, imaging, and metabolic flux approaches is currently used in the lab
Following up with the new paradigm revealed about uridine metabolism by Drs. Deng and Scherer (Science, 2017), the Deng lab is currently focusing on three areas: 1) the role of uridine in the progression of obesity and diabetes. 2) the physiology of uridine in bile and nutrient absorption. 3) the regulation of uridine homeostasis by ER stress and its relevance to breast cancer

Qualification

Ph.D. in biomedical sciencesAnimal models experienceLipid metabolism expertiseMolecular biology skillsMetabolomics experienceLiver physiology knowledge

Required

Ph.D. and/or M.D. degree in life or biomedical sciences or a related discipline is required
Experience in basic molecular biology skills
Experience in animal models and lipid metabolism
Experience in metabolomics and liver physiology
To Apply, please attach a cover letter describing your past training and research interests, a detailed CV and contact information of three referees

Preferred

Expertise in using mouse models to study metabolic diseases is preferred

Company

City of Hope

company-logo
City of Hope is a cancer research and treatment non-profit organization specializing in diabetes and other life-threatening illnesses.

Funding

Current Stage
Late Stage
Total Funding
$10.3M
Key Investors
California Institute for Regenerative Medicine
2024-05-20Grant· $5.4M
2022-02-22Grant· $4.9M

Leadership Team

leader-logo
Samuel Lau
Vice President Marketing & Digital Communications
linkedin
leader-logo
Alan H. Bryce
Chief Clinical Officer
linkedin
Company data provided by crunchbase